Study to Evaluate Whether BLI-489 Can be Safely Tolerated by Healthy Subjects Given Multiple Doses

Completed · Phase 1 · Has a placebo group

Conditions studied: Healthy

In brief

To determine the safety, tolerability, and drug absorption profile of multiple IV doses of BLI 489 in healthy subjects.

Key facts

Study ID
NCT00909688
Run by
Wyeth is now a wholly owned subsidiary of Pfizer
People needed
16
Starts
2009-06-05
Expected to finish
2009-07-24
Last updated by the study team
2018-09-27

Who can join

Age: 18 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.